<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of this study was to investigate the prevalence and possible association of inherited prothrombotic risk factors in children with <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo>, or <z:hpo ids='HP_0002076'>migraine</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We performed genotypic analysis for factor V G1691A, factor II G20210A, <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase C677T, and 4 common platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> polymorphisms (human platelet alloantigen-1, -2, -3, and -5) in 150 children &lt;18 years of age with established diagnoses of <z:hpo ids='HP_0001297'>stroke</z:hpo>, <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo>, or <z:hpo ids='HP_0002076'>migraine</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Children were classified into 5 groups, namely, childhood arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (N = 33), perinatal arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> (N = 26), hemorrhagic <z:hpo ids='HP_0001297'>stroke</z:hpo> (N = 20), <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (N = 36), and <z:hpo ids='HP_0002076'>migraine</z:hpo> (N = 35) </plain></SENT>
<SENT sid="3" pm="."><plain>The control group consisted of 112 children &lt; or =18 years of age from the same geographical region who had no history of neurologic or <z:hpo ids='HP_0001907'>thromboembolic diseases</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Heterozygosity for factor V G1691A was associated with approximately sevenfold increased risk for arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, perinatal arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, and <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Increased risk for <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> was found in carriers of the human platelet alloantigen-2b allele, human platelet alloantigen-5a/b genotype, and combined human platelet alloantigen-2b and human platelet alloantigen-5b genotype </plain></SENT>
<SENT sid="6" pm="."><plain>The presence of the human platelet alloantigen-2b allele was associated with a 2.23-fold increased risk for <z:hpo ids='HP_0002076'>migraine</z:hpo>, whereas carriers of the human platelet alloantigen-3b allele had a lower risk for arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> than did carriers of the human platelet alloantigen-3a allele </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Factor V G1691A has an important role in susceptibility to arterial <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo>, both in the perinatal/neonatal period and in childhood, as well as <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>A minor impact of human platelet alloantigen polymorphisms suggests that platelet <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> polymorphisms may increase the risk of <z:hpo ids='HP_0002326'>transient ischemic attacks</z:hpo> and <z:hpo ids='HP_0002076'>migraine</z:hpo>, but this should be confirmed in larger studies </plain></SENT>
</text></document>